<DOC>
	<DOC>NCT00675740</DOC>
	<brief_summary>The aim of this study is to prospectively assess the relative benefits of either treatment with rosiglitazone or physical exercise on endothelial function in patients with impaired fasting glucose or impaired glucose tolerance and coronary artery disease (CAD).</brief_summary>
	<brief_title>Physical Exercise Versus Rosiglitazone in CAD and Prediabetes</brief_title>
	<detailed_description />
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>impaired fasting glucose or impaired glucose tolerance angiographic evidence of coronary artery disease diabetes mellitus type I or II preexisting antidiabetic medication unstable angina indication for coronary bypass surgery significant left main disease myocardial infarction within preceding 3 months ejection fraction &lt; 40% significant heart valve disease severe metabolic disorders severe disorders in lipoprotein metabolism thyroid disorders alcohol or drug abuse pregnancy participation in another trial</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>